EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome

Xiaoying Song, Lijiao Xiong, Tianting Guo, Xue Chen, Pinjun Zhang iD, Xiaoan Zhang iD, Zhen Liang iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Xiaoying Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Department, Ganzhou People's Hospital, Ganzhou, Jiangxi Province, 341000, China. Hauptthemen laut MEDLINE: Cystatin C, Metabolic Syndrome, Cardiovascular Diseases, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Planning Project of Shenzhen City, Guangdong Province, China, Science and Technology Program of Jiangxi Provincial Administration of Traditional Chinese Medicine, Science and Technology Planning Project of Jiangxi Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study examined the relationship between cystatin C (CysC) levels and all-cause, cardiovascular disease (CVD), and cancer mortality in US metabolic syndrome (MetS) patients.

Methods

The 1999-2002 National Health and Nutrition Examination Survey (NHANES) prospective cohort research included 1980 MetS participants. To assess CysC levels and all-cause, CVD, and cancer mortality, fitted curves, Kaplan-Meier survival curves, Cox regression analysis, and receiver operating characteristic curves were performed.

Results

During a mean follow-up of 15.3 ± 5.4 years, a total of 819 deaths occurred. The fitted and Kaplan-Meier survival curves revealed that greater CysC levels were linked to higher all-cause, CVD, and cancer mortality rates (P < .05). After adjusting for variables, CysC level was associated with all-cause, CVD, and cancer mortality at 1.63 (1.42-1.88), 1.53 (1.19-1.95), and 1.53 (1 ∼ 2.32), respectively (P < .05). Tertile models showed consistent results: high CysC Tertile participants showed higher risk of all-cause mortality (HR 1.87; 1.43-2.45), CVD mortality (HR 1.97, 1.15 ∼ 3.38), and cancer mortality (HR 1.72, 1.01 ∼ 2.91) compared to those in the lowest tertile (P < .05). Subgroup studies by sex and other characteristics confirmed the findings. CysC demonstrated the higher predictive efficacy across mortality outcomes, followed by eGFR, outperforming urea nitrogen, creatinine, uric acid, and C-reactive protein. CysC alone exhibited substantial predictive value for all-cause (AUC 0.773; P < .05) and CVD mortality (AUC 0.726; P < .05). Combining CysC with age enhanced predictive value for all-cause mortality to 0.861 and CVD mortality to 0.771 (P < .05).

Conclusion

MetS patients with elevated CysC levels have a higher risk of all-cause, CVD, and cancer death. CysC may predict MetS all-cause and CVD mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystatin CMetabolic SyndromeCardiovascular DiseasesNeoplasmsNutrition SurveysHumansMaleFemaleMiddle AgedAdultUnited StatesProspective StudiesBiomarkersCause of DeathPrognosisFollow-Up StudiesAgedPredictive Value of TestsRisk Factors

Stichwörter der Autor:innen

CVD mortalityCystatin Call-cause mortalitycancer mortalitymetabolic syndromeprognostic marker

Substanzen

Cystatin CBiomarkersCST3 protein, human

Autor:innen und Institutionen

  • Medical Department, Ganzhou People's Hospital, Ganzhou, Jiangxi Province, 341000, China.
  • Department of Geriatrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, 518000, China.
  • Ganzhou Hospital of Guangdong Provincial People's Hospital (Ganzhou Municipal Hospital), Ganzhou, Jiangxi Province, 341000, China.
  • Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hos…
  • Gannan Medical University, Ganzhou, Jiangxi Province, 341000, China.

ORCID-Profile: Pinjun Zhang, Xiaoan Zhang, Zhen Liang

Förderung

  • Science and Technology Planning Project of Shenzhen City, Guangdong Province, China
  • Science and Technology Program of Jiangxi Provincial Administration of Traditional Chinese Medicine
  • Science and Technology Planning Project of Jiangxi Provincial Health Commission
  • Ganzhou Municipal Science and Technology Plan Project

Zitieren

APA

Song, X., Xiong, L., Guo, T., Chen, X., Zhang, P., Zhang, X., & Liang, Z. (2024). Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae225

Vancouver

Song X, Xiong L, Guo T, Chen X, Zhang P, Zhang X, et al. Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae225

BibTeX
@article{Song2024,
  author = {Song, Xiaoying and Xiong, Lijiao and Guo, Tianting and Chen, Xue and Zhang, Pinjun and Zhang, Xiaoan and Liang, Zhen},
  title = {Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae225}
}
Kostenlos starten →